Pharmacological Activities, Therapeutic Effects, and Mechanistic Actions of Trigonelline
International Journal of Molecular Sciences · 16.03.2024 · 25 (6) · 3385
DOI: 10.3390/ijms25063385 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 16.03.2024. Verfasst von Vi Nguyen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology and Anatomy, School of Medicine, University of South Carolina, Columbia, SC 29209, USA. Hauptthemen laut MEDLINE: Alkaloids, Diabetes Mellitus. Die Arbeit wurde bisher 112-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, NCATS NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Trigonelline (TRG) is a natural polar hydrophilic alkaloid that is found in many plants such as green coffee beans and fenugreek seeds. TRG potentially acts on multiple molecular targets, including nuclear factor erythroid 2-related factor 2 (Nrf2), peroxisome proliferator-activated receptor γ, glycogen synthase kinase, tyrosinase, nerve growth factor, estrogen receptor, amyloid-β peptide, and several neurotransmitter receptors. In this review, we systematically summarize the pharmacological activities, medicinal properties, and mechanistic actions of TRG as a potential therapeutic agent. Mechanistically, TRG can facilitate the maintenance and restoration of the metabolic homeostasis of glucose and lipids. It can counteract inflammatory constituents at multiple levels by hampering pro-inflammatory factor release, alleviating inflammatory propagation, and attenuating tissue injury. It concurrently modulates oxidative stress by the blockage of the detrimental Nrf2 pathway when autophagy is impaired. Therefore, it exerts diverse therapeutic effects on a variety of pathological conditions associated with chronic metabolic diseases and age-related disorders. It shows multidimensional effects, including neuroprotection from neurodegenerative disorders and diabetic peripheral neuropathy, neuromodulation, mitigation of cardiovascular disorders, skin diseases, diabetic mellitus, liver and kidney injuries, and anti-pathogen and anti-tumor activities. Further validations are required to define its specific targeting molecules, dissect the underlying mechanistic networks, and corroborate its efficacy in clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cell Biology and Anatomy, School of Medicine, University of South Carolina, Columbia, SC 29209, USA.
- TritaliMed, Inc., Columbia, SC 29223, USA.
- Applied Physics Program, California State University San Marcos, San Marcos, CA 92096, USA.
- Dalton Cardiovascular Research Center, Department of Medical Pharmacology and Physiology, School of Medicine, University of Missouri, Columbia, MO 65211, USA.
- Department of Biomedical Engineering, College of Engineering and Computing, University of South Carolina, Columbia, SC 29208, USA.
ORCID-Profile: Vi Nguyen, Wenbin Tan
Förderung
- NIAMS NIH HHS
- NCATS NIH HHS
- NHLBI NIH HHS
- NIH HHS
- National Institute of Arthritis and Musculoskeletal
- Skin Diseases of the National Institutes of Health
- Department of Defense
- National Heart, Lung, and Blood Institute
Zitieren
APA
Nguyen, V., Taine, E. G., Meng, D., Cui, T., & Tan, W. (2024). Pharmacological Activities, Therapeutic Effects, and Mechanistic Actions of Trigonelline. International Journal of Molecular Sciences, 25(6), 3385. https://doi.org/10.3390/ijms25063385
Vancouver
Nguyen V, Taine EG, Meng D, Cui T, Tan W. Pharmacological Activities, Therapeutic Effects, and Mechanistic Actions of Trigonelline. International Journal of Molecular Sciences. 2024;25(6):3385. doi:10.3390/ijms25063385
BibTeX
@article{Nguyen2024,
author = {Nguyen, Vi and Taine, Elaine G and Meng, Dehao and Cui, Taixing and Tan, Wenbin},
title = {Pharmacological Activities, Therapeutic Effects, and Mechanistic Actions of Trigonelline},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {6},
pages = {3385},
doi = {10.3390/ijms25063385}
}
EUVIMED